FDA Approvals

Date Posted
Article Title
12/11/2015
Vistogard Approved for Chemotherapy Overdose

For drugs often prescribed to treat breast, colon cancers

12/9/2015
Cooling Cap to Reduce Chemo-Linked Hair Loss OK'd

Designed for women diagnosed with breast cancer

12/8/2015
Vonvendi Approved to Control Bleeding Disorder

Clotting factor sanctioned for von Willebrand disease

12/8/2015
Kanuma Approved for Rare Missing-Enzyme Disease

Wolman disease triggers fat buildup, leading to heart and liver problems

11/30/2015
Empliciti Approved for Multiple Myeloma

Drug boosts immune system to destroy cancer cells

11/24/2015
Portrazza Approved for Advanced Lung Cancer

The top cause of cancer death in the United States

11/24/2015
Opdivo Approved for Advanced Kidney Cancer

More than 14,000 projected to die from disease this year

11/24/2015
Anthrax Vaccine Approval Expanded

Now sanctioned for adults 18 to 65 with known or suspected exposure

11/20/2015
Ninlaro Approved for Multiple Myeloma

Blocks certain enzymes, hindering cancer-cell growth

11/19/2015
Narcan Nasal Spray Approved to Counter Narcotic Painkiller Overdose

First-of-its-kind drug sanctioned to reverse effects of heroin or oxycodone use

11/16/2015
Darzalex Approved for Multiple Myeloma

For people who have received other treatments

11/10/2015
Cotellic Approved for Advanced Melanoma

Nearly 10,000 projected to die this year from deadly skin cancer

10/28/2015
Injected Drug Approved for Melanoma Skin Cancer

Imlygic designed to rupture and kill cancer cells

10/23/2015
Onivyde Approved for Advanced Pancreatic Cancer

Thousands projected to die from hard-to-treat disease

10/23/2015
New Drug Approved for Soft-Tissue Cancer

Disease most often affects head, neck, extremities and torso

10/21/2015
Coagadex Approved for Rare Clotting Disorder

First coagulation therapy sanctioned for Factor X deficiency

10/6/2015
Aristada Approved for Schizophrenia

Long-acting drug injected every four-to-six weeks

10/6/2015
Optune Device Approved for Newly Diagnosed Brain Cancer

Emits electric pulses designed to thwart tumor growth

10/2/2015
Keytruda Approved for Leading Form of Lung Cancer

Helps immune system fight non-small cell lung cancer

9/22/2015
Lonsurf Approved for Advanced Colon Cancer

Among people who aren't responding to other treatments